Registration Strip Icon for charts 실시간 차트, 분석 도구 및 가격을 받으려면 등록하세요.

BOLD

Boundless Bio (BOLD)

Boundless Bio Inc
일자:
정렬 기준:
 검색 관련기사 보기:NASDAQ:BOLD
일자시간출처헤드라인심볼기업
2019/05/0805:05Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:BOLDBoundless Bio Inc
2019/05/0805:01PR Newswire (US)Audentes Therapeutics Reports First Quarter 2019 Financial Results and Provides Corporate UpdateNASDAQ:BOLDBoundless Bio Inc
2019/05/0203:17Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:BOLDBoundless Bio Inc
2019/05/0203:15PR Newswire (US)Audentes Therapeutics Presents New Positive Data from ASPIRO, the Phase 1/2 Clinical Trial of AT132 for X-linked Myotubular M...NASDAQ:BOLDBoundless Bio Inc
2019/04/3021:00PR Newswire (US)Audentes Therapeutics to Release First Quarter 2019 Financial Results and Provide Corporate Update on Tuesday, May 7, 2019NASDAQ:BOLDBoundless Bio Inc
2019/04/2707:00PR Newswire (US)Audentes Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:BOLDBoundless Bio Inc
2019/04/2705:38Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:BOLDBoundless Bio Inc
2019/04/2705:37Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:BOLDBoundless Bio Inc
2019/04/2321:00PR Newswire (US)Audentes Therapeutics Announces Launch of New State-of-the-Art Internal cGMP Plasmid Manufacturing FacilityNASDAQ:BOLDBoundless Bio Inc
2019/04/1605:01PR Newswire (US)Audentes Therapeutics Announces Upcoming Presentations at 22nd Annual Meeting of the American Society of Gene and Cell Therap...NASDAQ:BOLDBoundless Bio Inc
2019/04/0820:12Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:BOLDBoundless Bio Inc
2019/04/0820:00PR Newswire (US)Audentes Therapeutics Announces Expansion of AAV Technology Platform and Pipeline with New Development Programs for Duchenne ...NASDAQ:BOLDBoundless Bio Inc
2019/04/0607:00PR Newswire (US)Audentes Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:BOLDBoundless Bio Inc
2019/04/0206:55Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:BOLDBoundless Bio Inc
2019/04/0206:54Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:BOLDBoundless Bio Inc
2019/04/0121:00PR Newswire (US)Audentes Therapeutics Appoints Legal and Corporate Communications Executives; Promotes Thomas P. Soloway to Executive Vice Pr...NASDAQ:BOLDBoundless Bio Inc
2019/03/2806:05Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:BOLDBoundless Bio Inc
2019/03/2721:45InvestorWireAdvanced Medical Technologies Provide Unprecedented Targeting in Cancer TherapyNASDAQ:BOLDBoundless Bio Inc
2019/03/0908:00PR Newswire (US)Audentes Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:BOLDBoundless Bio Inc
2019/03/0207:48Edgar (US Regulatory)Annual Report (10-k)NASDAQ:BOLDBoundless Bio Inc
2019/02/2822:00PR Newswire (US)Audentes Therapeutics Recognizes Rare Disease Day by Launching "Be Bold for Courageous Patients" Program to Support Patients ...NASDAQ:BOLDBoundless Bio Inc
2019/02/2806:36Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:BOLDBoundless Bio Inc
2019/02/2806:35Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:BOLDBoundless Bio Inc
2019/02/2806:20Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:BOLDBoundless Bio Inc
2019/02/2806:01PR Newswire (US)Audentes Therapeutics Reports Fourth Quarter 2018 and Full Year Financial Results and Provides Corporate UpdateNASDAQ:BOLDBoundless Bio Inc
2019/02/2122:00PR Newswire (US)Audentes Therapeutics to Release Fourth Quarter and Full Year 2018 Financial Results and Provide Corporate Update on Wednesda...NASDAQ:BOLDBoundless Bio Inc
2019/02/2022:00PR Newswire (US)Audentes Therapeutics to Participate in Upcoming Investor ConferencesNASDAQ:BOLDBoundless Bio Inc
2019/02/1507:26Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:BOLDBoundless Bio Inc
2019/02/1506:16Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:BOLDBoundless Bio Inc
2019/02/1504:10Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:BOLDBoundless Bio Inc
 검색 관련기사 보기:NASDAQ:BOLD